Miracle Herb 2000: A Look at the Evidence Ann Zweber and Roberto Linares Oregon State University College of Pharmacy Introduction Miracle Herb 2000 has.

Slides:



Advertisements
Similar presentations
09-Sep-2003 Predicting human risk with animal research: lessons learned from caffeine/ephedrine combinations Richard J. Briscoe, Ph.D. Safety Pharmacology.
Advertisements

Are topical NSAIDs a safe and effective treatment for Corneal Abrasions? Department of Emergency Medicine University of Pennsylvania Health System Andrew.
Farxiga™ - Dapagliflozin
CHAPTER 3 Life Span Considerations
Manufacturer: Celgene Corporation FDA Approval Date: 9/23/14
What Do Toxicologists Do?
Sivextro™ (tedizolid phosphate)
Harvoni® ledipasvir/sofosbuvir
+ Drug Development and Review Process. + Objectives Learn the processes involved in drug discovery and development Define the phases involved in FDA drug.
CHAPTER 7 DIETARY SUPPLEMENTS. Chapter Objectives Define and explain the term “dietary supplements.” List reasons that people use supplements. Discuss.
Neonatal/Juvenile Animal Safety Studies Kenneth L. Hastings, Dr.P.H., D.A.B.T. Office of New Drugs, CDER.
Clinical Trials of Traditional Herbal Medicines In India Y.K.Gupta Professor & Head, Department of Pharmacology, All India Institute of Medical Sciences,
Personal and Consumer Health 1. Objectives 1.Demonstrate the ability to access and describe health information, health products, and health services in.
Biomedical research methods. What are biomedical research methods? An integrated approach using chemical, mathematical and computer simulations, in vitro.
Epanova ® - Omega-3- carboxylic acids Manufacturer: AstraZeneca FDA Approval Date: 05/2014.
From the Discussion Section of Johnston et al.'s Research Paper (1) The metabolic consequences of HP diets are controversial, but most experts agree that.
Stages of drug development
1 Lotronex ® (alosetron HCl) Tablets Risk-Benefit Issues Victor F. C. Raczkowski, M.D. Director, Division of Gastrointestinal and Coagulation Drug Products.
Afrezza® – inhaled human insulin
Dietary Supplements. Product, other than tobacco, intended to enhance the diet that contains one or more of the following dietary ingredients: vitamins,
1 Kepivance™ (Palifermin) Basis for Approval and Pediatric Studies Kepivance™ (Amgen) Approved 12/15/04 Joseph E. Gootenberg, M.D. Office of Oncology Drug.
Biomedical Research Objective 2 Biomedical Research Methods.
Biomedical Research.
What Are They? Who Needs them? What Are They? Who Needs them?
Dietary Supplements. Definition by DSHEA Product that is to supplement a healthy diet. Includes ingredients such as vitamins, minerals, herbs, botanicals,
Melatonin natural hormon regulation of sleep-wake rhythm successfully experienced in shift-workers, jet- lag, chronic insomnia first treatment for sleep.
Module IV: Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
Nutritional Supplements Samantha Klym HW499: Bachelor’s Capstone in Health and Wellness May 19, 2015.
Medicare Coordinated Care Demonstration May 13, 2003.
Lesson 36 Bellringer What does OTC stand for? Why do you need to read the label on OTC drugs? What is one consequence of drug abuse?
Chapter 7 (part 1): Proteins Foods: Fall Protein: The main Idea  Very important in the diet.  Contribute to growth and development.  Help the.
DIETARY SUPPLEMENTS Dietary supplements are products that can be added to people’s diets. They include vitamins, minerals, herbs, and amino acids.
Weight Loss Supplements Presented by Kelsie Schuman.
Bledsoe et al., Paramedic Care Principles & Practice Volume 1: Introduction © 2006 by Pearson Education, Inc. Upper Saddle River, NJ Basic Pharmacology.
History of Pediatric Labeling
Perspectives on Enhancing Consumer Outcomes with Topical Antifungals
Introduction to Pharmacology. ORIENTATION TO PHARMACOLOGY Objectives: 1. Definition of the four basic terms (drug, pharmacology, clinical pharmacology,
Sprout Pharmaceuticals Inc. FDA Approval Date: August 18, 2015
CLINICAL EFFICACY TESTING for NASAL DRUGS Mary M. Fanning, M.D., Ph.D. Associate Director for Medical Affairs Office of Generic Drugs, FDA June 4, 1999.
Focus on Nursing Pharmacology
1 Markham C. Luke, M.D., Ph.D. Dermatology Clinical Team Leader DDDDP, ODE V, CDER, FDA Combination Topical Products for the Treatment of Acne Vulgaris.
General Regulatory Issues in the Development of Drugs Intended for Treatment of Chronic Illness Sharon Hertz, M.D. Medical Officer Division of Anesthetic,
Pharmacogenetics.
A. Bazrafshan, MD Felloweshipe of Pediatric Hematology-Oncology Shiraz University of Medical Science Shiraz – Iran
Modified release products. Considerations in the evaluation of modified release products Requirements for preparing extended release products. The bioavailability.
Manufacturer: Amgen Inc FDA Approval Date: August 27, 2015
Principles of Pharmacology Brenda Rowe, RN, MN, JD.
Manufacturer: AstraZeneca FDA Approval Date: December 22, 2015
OVER THE COUNTER MEDS INTRODUCTION No prescriptions are necessary and no questions need to be answered to attain these drugs OTC med use saves.
Drug efficacy is questioned.. Variation in drug responses.
Manufacturer: Relypsa Inc. FDA Approval Date: October 21, 2015
NUTRITION: HERBAL SUPPLEMENTS- EFFICACY & SAFETY by Dominique Hall Biology 1310 Professor Lang.
Section I General principle of Pharmacology. Where can you get information about general principle of Pharmacology?  Text books:  Katzung, Basic and.
1 Clinical Studies Section of Labeling Joseph Porres, M.D., Ph.D. Medical Officer Division of Dermatologic and Dental Drug Products FDA.
Rayaldee® - calcifediol
Adlyxin® - Lixisenatide
Nuplazid™ - Pimavanserin
Metreleptin Drugbank ID :DB09046
Eucrisa™ - Crisaborole
Copyright © 2016 by Mosby, an imprint of Elsevier Inc.
Dietary and Herbal Supplements
Life Span Consideration
Introduction of Biopharmaceutics & Pharmacokinetics
CHAPTER 7 DIETARY SUPPLEMENTS
Presented By: Sumia Khan
GI Disorders.
Pharmacologic Principles – Chapter 2
Principles of Pharmacology
Endari (L-Glutamine)for sickle Cell Disease
Objective 2 Biomedical Research Methods
Presentation transcript:

Miracle Herb 2000: A Look at the Evidence Ann Zweber and Roberto Linares Oregon State University College of Pharmacy Introduction Miracle Herb 2000 has been used for weeks in several regions of Kentucky. Natives claim it cures warts and syphilis, as well as cause weight loss. Although many claims have been made, there is little evidence for safety and efficacy. Miracle Herb 2000 is a small shrub that grows on gravel roadsides. It is characterized by small pink leaves, and spikes on stems. Traditionally, the spikes are harvested in the fall and ground into a paste to apply to affected areas. Biochemistry Several studies of active constituents of Miracle Herb 2000 have been reported in the literature. MH 2000 contains a variety of flavones and terpenes which may contribute to its effects 1. One component, alpha hydroxy mega terpene has a unique, and highly unstable pyridine ring system which may disrupt sulfhydryl bonds in susceptible amino acids 2. Drug Action Absorption: Studies of the active components of MH 2000 have demonstrated that several of the are acid labile. Only one product currently available is an enteric coated tablet, possibly circumventing rapid inactivation by gastric acid. Distribution: No studies have been conducted to determine the distribution of MH xxxx is highly water soluble, indicating that if it is absorbed intact it would not likely distribute to fat tissues Metabolism and excretion: Urinalysis of patients using enteric coated MH 2000 found 15%, 25% and 25% of xxxx excreted unchanged at 4, 6 and 8 hours. Clinical Data Several small studies have been conducted to evaluate the efficacy of Miracle Herb 2000 for the treatment of warts. Results have been inconclusive Yoder, et al 5 conducted a randomized placebo controlled trial with 17 patients and found that Miracle Herb 2000 was no better than placebo for the elimination of warts on elbows. A summary chart would be nice here Wu, Smith, and Holler 6 conducted an open label trial with patients with chronic warts. After a six week treatment with a 10% solution of Miracle Herb 2000, 65% of the patients reported a reduced number and size of warts. Precautions and possible complications Because of the potential teratogenic effects, MH 2000 should not be used in pregnant of nursing women Animal studies in rats have shown an increase in tumor growth. Patients who are allergic to plants in the Family Micicaceae should not use Miracle Herb Unwanted effects of Miracle Herb 200 have been reported in some studies. These include: Excessive hair growth (35%) Constipation (14%) Insomnia(5%) Anhedonia (3%) Because Miracle Herb 2000 is metabolized by the cytochrome P450 3A4 enzyme, it may increase levels of the following medications: Yrgiptamine Somalopram Kegrololol MH 2000 may have an additive effect with: Jernilamine Pancreopril Comparison to Conventional Medicine The FDA has approved 3 other treatments for warts. Salicylic acid gel and patches are available without a prescription, and podophyllum toxin is used in a physician’s office. A comparison table of efficacy, treatment regimes, adverse effects, safety, and costs is provided below: MH 2000Salicylic acid gel Salicylic acid patches Podophyllu m toxin Efficacy20%60%63%70% TreatmentApply 6 times daily for 6 months Twice daily for 6 weeks Every 48 hours for 6 weeks Once with follow up in two weeks Adverse effects Excessive hair growth, hernias, cancer Local irritation Local irritation, toxic to … SafetyUnknownContraindi cated in diabetes Contraindic ated in children Costs$4000 for 6 month (full) treatment $15 for 6 weeks (full) treatment $20 for 6 weeks (full) treatment Office visit $75 plus treatment $25 Conclusion The safety and efficacy for Miracle Herb 2000 has not been established. Since herbal products are not regulated by the FDA, quality and standardization of products cannot be assured. Although Miracle Herb 2000 may be safe in small amounts for patients without contraindications, lack of support for its efficacy does not warrant recommendations for use at this time. Conventional treatments not only offer better data to support their use, but they may also be more cost effective and have less adverse effects. References 1 2 3